Amgen Exec: PBMs Factor Patient Cost Sharing Into Drug Net Prices

By John Wilkerson / May 15, 2019 at 3:32 PM
Pharmacy benefit managers often don't favor drugs with lower list prices, even when the discounted (net) price equals that of an identical drug with a higher list price, because patients pay more to insurers for the high-list-price drug, and that bigger patient cost sharing amount is factored into net prices used to gain placement on formularies, an Amgen executive told House Energy & Commerce health subcommittee members Thursday (May 9). Administrative fees that pharmacy benefit managers charge also are factored...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.